Choice of Long-Acting Insulin Therapy for Type 2 Diabetes: How Can Treatment for Older People be Optimized?

Author： Krentz Andrew J.   Sinclair Alan J.  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.28, Iss.12, 2011-12, pp. : 935-941

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Insulin detemir is an effective long-acting human insulin analogue for the treatment of type 1 and 2 diabetes mellitus

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 21, Iss. 9, 2005-09 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

Differences between long-acting insulins for the treatment of type 2 diabetes

By Jensen Michael Gejl   Hansen Mikkel   Brock Birgitte   Rungby Jørgen  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 12, 2010-08 ,pp. : 2027-2035

Informa Healthcare

Access to resources Recommend Favorite

Insulin Glargine: A Review of its Therapeutic Use as a Long-Acting Agent for the Management of Type 1 and 2 Diabetes Mellitus

By McKeage K.   Goa K.L.  

Drugs, Vol. 61, Iss. 11, 2001-01 ,pp. : 1599-1624

Adis International

Access to resources Recommend Favorite

Insulin Therapy in Diabetes Mellitus: How Can the Currently Available Injectable Insulins be Most Prudently and Efficaciously Utilised?

By Bell David S.H.  

Drugs, Vol. 67, Iss. 13, 2007-01 ,pp. : 1813-1827

Adis International

Access to resources Recommend Favorite

Inhaled insulin beneficial in type 2 diabetes?

By  

Inpharma, Vol. 1, Iss. 1277, 2001-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite